Medifast

Medifast, Inc. engages in the provision of healthy living products and programs. It offers the OPTAVIA brand, a lifestyle solution centered on developing new healthy habits through smaller, foundational changes called micro-habits. The firm’s product line includes bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups. The company was founded by William Vitale in 1981 and is headquartered in Baltimore, MD.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Medifast reports Q4 revenue decline, focuses on cost management

Medifast's Q4 2022 performance saw revenue decline but strong cost management and cash generation.
Challenges include revenue outlook for Q1 2023 and competitive landscape in weight loss and coaching markets.
Opportunities lie in capital allocation strategies, maintaining shareholder value, and adapting to market trends.
Overall, Medifast remains focused on long-term growth, financial stability, and delivering on its mission.

Medifast surpasses Q1 expectations, eyes growth amid operational tweaks

Medifast's Q1 2023 performance exceeded expectations, with a focus on revenue growth and cost control measures.
Despite challenges like decreased active coaches, the company is well-positioned with a strong financial standing and growth initiatives.
Opportunities in customer acquisition, cost-saving efforts, market expansion, and innovative solutions pave the way for future success.
Guidance for Q2 2023 reflects a strategic approach to balancing growth and profitability amidst market dynamics and operational changes.

Medifast reports Q2 revenue decline, eyes sustainable growth strategies

Medifast navigated challenges in Q2 2023 with improved operating margin and strategic market exits.
The company's focus on new growth initiatives and cost-saving measures reflects adaptability to market dynamics.
While facing revenue declines and competitive pressures, Medifast aims for sustainable growth with clear targets.
Exploration of medically supported weight loss solutions and new product lines offer avenues for future expansion.

Medifast reports resilient Q3 performance, eyes growth through diversification

Medifast's Q3 performance reflects resilience amid revenue decline, with a focus on operational efficiency and financial strength. While facing challenges in revenue and expense management, the company remains agile and proactive in exploring growth opportunities through market expansion and social responsibility initiatives.

Medifast transitions to health and wellness focus amidst revenue challenges

Medifast is navigating challenges in customer acquisition and macro factors while focusing on becoming a diversified health and wellness company.
The company's strategic collaboration with Life MD and new product offerings position it for growth.
While Q4 2023 saw a revenue decrease, Medifast's improved gross profit margin and cost-saving initiatives demonstrate operational efficiency.
Investors should monitor the impact of increased marketing spending on operating margin and EPS in the coming years.

Medifast faces revenue decline due to weight loss medication trends

Medifast's Q1 2024 performance reflects challenges in revenue and income, driven by difficulties in customer acquisition amidst weight loss medication trends.
Despite the decline, the company demonstrated operational efficiency with improved gross profit margins and cost management.
Investments in marketing and collaborations present opportunities for future growth and market expansion, signaling a strategic focus on long-term success.
Navigating market challenges while capitalizing on opportunities will be crucial for Medifast's resilience and competitiveness in the weight loss industry.

Medifast reports Q2 losses, focuses on growth strategies and cost management

Medifast's Q2 2024 performance reflects a challenging period marked by revenue and profit declines, offset by margin improvements and cost reductions.
The company's strategic initiatives aim to drive long-term growth and enhance operational efficiency amidst macroeconomic headwinds and lower coach productivity.
While facing financial setbacks, Medifast's focus on targeted advertising, product diversification, and cost management signifies a proactive stance towards future recovery and growth.

Medifast adapts to industry changes with tailored programs and innovations

Medifast's Q3 2024 performance reflected revenue and net income declines, highlighting challenges in the weight loss industry.
Despite these challenges, the company's strategic focus on tailored programs, strong financial position, and new product launches indicate a proactive approach to addressing market dynamics.
Opportunities in clinical studies, new product launches, and financial strength position Medifast for potential growth and market expansion in the future.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Medifast, Inc. engages in the provision of healthy living products and programs. It offers the OPTAVIA brand, a lifestyle solution centered on developing new healthy habits through smaller, foundational changes called micro-habits. The firm's product line includes bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups. The company was founded by William Vitale in 1981 and is headquartered in Baltimore, MD.

Market-thumping sales growth is holding up through early 2021.

Why Medifast Stock Jumped 46% in May

Medifast (MED) reported earnings 30 days ago. What's next for the stock?

Why Is Medifast (MED) Up 27.6% Since Last Earnings Report?

Does Medifast (MED) have what it takes to be a top stock pick for momentum investors? Let's find out.

What Makes Medifast (MED) a Strong Momentum Stock: Buy Now?

If you are looking for stocks that are well positioned to maintain their recent uptrend, Medifast (MED) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

Medifast (MED) is on the Move, Here's Why the Trend Could be Sustainable

Medifast (MED) has been benefiting from its OPTAVIA lifestyle solution and coaching support system. Additionally, the company has been speeding up its long-term supply-chain efforts.

Medifast (MED) Looks Appetizing, OPTAVIA Solution a Key Upside

Dillard's

Olin

PDC Energy Inc

Tsakos Energy Navigation Ltd

We have narrowed down our search to five growth stocks that have popped more than 10% in the past month. These are; MED, TEN, DDS, OLN and PDCE.

5 High-Flying Growth Stocks to Buy Despite Inflation Concern

As of late, it has definitely been a great time to be an investor of Medifast (MED)

Can the Rally in Medifast (MED) Shares Continue?

Expeditors International of Washington

Haverty Furniture Companies

Smith & Wesson Brands

Here are four top-ranked liquid stocks -- MED, SWBI, HVT and EXPD -- that investors can bank on for impressive returns for a winning portfolio.

4 Top-Ranked Liquid Bets to Build a Successful Portfolio

Delta Apparel

Genco Shipping & Trading

Star Bulk Carriers

Townsquare Media

Investors target stocks that are witnessing a bullish run. Actually, stocks seeing price strength like GNK, SBLK, TSQ, MED and DLA have a high chance of carrying the momentum forward.

5 Stocks With Recent Price Strength Amid Inflation Concern

Medifast (MED) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

What Makes Medifast (MED) a Good Fit for "Trend Investing"

Booz Allen Hamilton Hld

Best Buy

Domino's Pizza

Johnson Outdoors

Mastercard

MarketAxess Holdings

MSCI

Old Dominion Freight Line

Universal Display

Primerica

Sherwin-Williams

S&P Global

T. Rowe Price Group

Tractor Supply

Texas Instruments

Zoetis

Fast growing dividends may have low initial yields but will grow rapidly over time.

Boost Your Future Income With These Fast Growing Dividends

The Zacks Rank offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.

Looking for Consumer Staples Stocks? The Zacks Rank Can Help You Find Winners

Andersons

ArcBest

Gray TV

Rent-A-Center

Diversify your portfolio to include some mid-cap stocks.

5 Mid-Cap Stocks That Reported Solid Q1 Results

Medifast (MED) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

Medifast (MED) Moves 12.1% Higher: Will This Strength Last?

Medifast's (MED) first-quarter 2021 results reflect robust earnings and sales growth. The company continued to gain on solid OPTAVIA performance, courtesy of a rise in active earning coaches.

Medifast (MED) Stock Gains on Q1 Earnings & Revenue Beat

Medifast (MED) delivered earnings and revenue surprises of 27.21% and 18.71%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Medifast (MED) Tops Q1 Earnings and Revenue Estimates

Medifast, Inc. (MED) CEO Dan Chard on Q1 2021 Results - Earnings Call Transcript

BALTIMORE, May 4, 2021 /PRNewswire/ -- Medifast, Inc. (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities,  OPTAVIA® , today reported results for the first quarter ended March 31, 2021. First Quarter 2021 Highlights Compared to the Prior-Year Period Revenue increased 90.9% to $340.7 million 61.0% growth in active earning OPTAVIA Coaches to a record level of 52,500 Revenue per active earning OPTAVIA Coach increased 21.0% to $6,454 Net income increased 122.2% to $41.1 million Earnings per diluted share ("EPS") of $3.46, an increase of 121.8% "This has been an exceptional quarter of growth and productivity, reflecting the outstanding abilities of both our independent OPTAVIA Coaches and our employees," said Dan Chard, Chairman and Chief Executive Officer of Medifast.

Medifast, Inc. Announces First Quarter 2021 Financial Results

Strength in the OPTAVIA lifestyle solution and coaching support system have most likely aided Medifast's (MED) first-quarter 2021 performance.

Here's How Medifast (MED) is Placed Ahead of Q1 Earnings

Medifast is near a buy zone with earnings due on or around May 4. The post Stocks To Watch Ahead Of Earnings: Medifast appeared first on Investor's Business Daily.

Stocks To Watch Ahead Of Earnings: Medifast

BALTIMORE, April 20, 2021 /PRNewswire/ -- Medifast, Inc. (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, will announce financial results for the first quarter ended March 31, 2021 on Tuesday, May 4, 2021, after market close. The Company will host a conference call to discuss these results with additional comments and details.

Medifast, Inc. to Announce Financial Results for the First Quarter Ended March 31, 2021

Medifast has grown its revenues and earnings double digits since 2017. The stock performance has been outstanding as the price increased from $18 to $222 in 10 years which results in an annual return of 28.6%.

Medifast - A Fast Growing Stock For Dividend Investors

Medifast (MED) has been benefiting from its OPTAVIA lifestyle solution and coaching support system, which is well placed given consumers' rising inclination toward health and wellness.

Medifast (MED) Rallies More Than 25% in 6 Months: Here's Why

Why Is Medifast (MED) Down 11.9% Since Last Earnings Report?

CareTrust REIT

Dollar General

Fulton Financial

Horizon

Independent Bank

Investar Hhld

MGM Growth Properties

Realty Income Corp

Shoe Carnival

WD-40

Williams-Sonoma

This article series provides a weekly summary of dividend changes. A table with relevant data and key statistics of dividend increases is provided.

Dividend Increases: March 13-19, 2021

News for Medifast Stock (MED)